Changchun High-Tech Industries (000661.SZ): The cooperative product Pediatric Gold Cough Granules has been approved for sale domestically.

Changchun High-Tech Industries (000661.SZ) issued an announcement, recently, the company's controlling subsidiary Changchun Jinsai Pharmaceutical Co., Ltd...

Zhitong FinanceJan 3 06:59 ET

Changchun High-Tech Industries (000661.SZ) has repurchased a total of 0.67% of its shares, spending approximately 0.3 billion yuan.

Changchun High-Tech Industries (000661.SZ) announced that as of December 31, 2024, the company has cumulatively...

Zhitong FinanceJan 2 06:51 ET

Changchun High-Tech Industry Group Gets Approval to Conduct Clinical Trials for Vaccine

MT NewswiresDec 26, 2024 03:33 ET

Changchun High-Tech Industries (000661.SZ): The international pharmaceutical industrial park is not yet fully formally put into production.

On December 26, Geloonghui reported that Changchun High-Tech Industries (000661.SZ) stated on its investor interaction platform that the international pharmaceutical industrial park has not yet fully started production. The company's newly constructed capacity has fully taken into account the production demands for the near future, and the relevant capacity should be based on the final quantities after formal production commences.

Gelonghui FinanceDec 26, 2024 03:12 ET

Are Robust Financials Driving The Recent Rally In Changchun High-Tech Industry (Group) Co., Ltd.'s (SZSE:000661) Stock?

Simply Wall StDec 24, 2024 19:28 ET

Changchun High-Tech Industries (000661.SZ): The clinical trial application for the type II simple herpes virus mRNA vaccine of the controlled subsidiary has been approved.

Gelonghui reported on December 20 that Changchun High-Tech Industries (000661.SZ) announced that its holding subsidiary - Changchun Baike Biotechnology Co., Ltd. (hereinafter referred to as "Baike Biotechnology") has received the approval notice for drug clinical trials issued by the National Medical Products Administration. The clinical trial application for the Type II herpes simplex virus mRNA vaccine has been approved. Type II herpes simplex virus infection, which leads to genital herpes, is a contagious disease primarily spread through sexual contact, characterized by easy transmission, recurrence, and a lack of effective cure, becoming a serious public health issue. To prevent the occurrence of genital herpes, already several...

Gelonghui FinanceDec 20, 2024 09:13 ET